» Authors » Cornelis E Hack

Cornelis E Hack

Explore the profile of Cornelis E Hack including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 216
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kardol-Hoefnagel T, Senejohnny D, Kamburova E, Wisse B, Reteig L, Gruijters M, et al.
HLA . 2024 Jan; 103(1):e15346. PMID: 38239046
In kidney transplantation, survival rates are still partly impaired due to the deleterious effects of donor specific HLA antibodies (DSA). However, not all luminex-defined DSA appear to be clinically relevant....
2.
Kardol-Hoefnagel T, Senejohnny D, Kamburova E, Wisse B, Gruijters M, Joosten I, et al.
HLA . 2024 Jan; 103(1):e15297. PMID: 38226401
In kidney transplantation, donor HLA antibodies are a risk factor for graft loss. Accessibility of donor eplets for HLA antibodies is predicted by the ElliPro score. The clinical usefulness of...
3.
Kamburova E, Gruijters M, Kardol-Hoefnagel T, Wisse B, Joosten I, Allebes W, et al.
Am J Transplant . 2019 Jun; 19(12):3335-3344. PMID: 31194283
The clinical significance of non-HLA antibodies on renal allograft survival is a matter of debate, due to differences in reported results and lack of large-scale studies incorporating analysis of multiple...
4.
Heidt S, Haasnoot G, Witvliet M, van der Linden-van Oevelen M, Kamburova E, Wisse B, et al.
Am J Transplant . 2019 Jun; 19(10):2926-2933. PMID: 31155833
Whereas regular allocation avoids unacceptable mismatches on the donor organ, allocation to highly sensitized patients within the Eurotransplant Acceptable Mismatch (AM) program is based on the patient's HLA phenotype plus...
5.
Kamburova E, Kardol-Hoefnagel T, Wisse B, Joosten I, Allebes W, van der Meer A, et al.
Front Immunol . 2019 Jan; 9:3002. PMID: 30631326
The best treatment for patients with end-stage renal disease is kidney transplantation. Although graft survival rates have improved in the last decades, patients still may lose their grafts partly due...
6.
Michielsen L, van Zuilen A, Verhaar M, Wisse B, Kamburova E, Joosten I, et al.
Nephrol Dial Transplant . 2018 Dec; 34(8):1417-1422. PMID: 30561730
Background: Few studies have evaluated the effect of different immunosuppressive strategies on long-term kidney transplant outcomes. Moreover, as they were usually based on historical data, it was not possible to...
7.
Michielsen L, Wisse B, Kamburova E, Verhaar M, Joosten I, Allebes W, et al.
Nephrol Dial Transplant . 2018 Oct; 34(6):1056-1063. PMID: 30365008
Background: Pre-transplant donor-specific anti-human leucocyte antigen (HLA) antibodies (DSAs) are associated with impaired kidney graft survival while the clinical relevance of non-donor-specific anti-HLA antibodies (nDSAs) is more controversial. The aim...
8.
Wisse B, Kamburova E, Joosten I, Allebes W, van der Meer A, Hilbrands L, et al.
Transplantation . 2018 Aug; 103(4):789-797. PMID: 30106794
Background: There is no consensus in the literature on the interpretation of single-antigen bead positive for a specific HLA antibody. Methods: To inform the debate, we studied the relationship between...
9.
Kamburova E, Wisse B, Joosten I, Allebes W, van der Meer A, Hilbrands L, et al.
J Am Soc Nephrol . 2018 Jul; 29(9):2279-2285. PMID: 30049681
Complement-fixing antibodies against donor HLA are considered a contraindication for kidney transplant. A modification of the IgG single-antigen bead (SAB) assay allows detection of anti-HLA antibodies that bind C3d. Because...
10.
Hillen M, Radstake T, Hack C, van Roon J
Rheumatology (Oxford) . 2015 Jul; 54(10):1771-9. PMID: 26163286
Thymic stromal lymphopoietin (TSLP) is an IL-7-related cytokine that has been studied extensively in atopic diseases and more recently in various rheumatic disorders. It is involved in T cell development...